Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Sep 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.74 | 10,880 | 127.73 k | 10,880 |
1 Mar 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.13 | 72,000 | 81.36 k | 72,000 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 18,750 | 18.00 k | 18,750 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 74,998 | 72.00 k | 74,998 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 58,822 | 56.47 k | 58,822 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.06 | 26,250 | 80.33 k | 0 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.06 | 105,000 | 321.30 k | 0 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.18 | 200,000 | 3.24 mm | 0 |
8 Sep 23 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.84 | 48,000 | 40.32 k | 48,000 |